Search CORE

7 research outputs found

Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2

Author: A. M. D. Kooistra-Smid
Anne M. Schijvens
AX Garg
C Mele
CM Legendre
E Espie
H Trachtman
John W. A. Rossen
Kioa L. Wijnsma
KL Wijnsma
L Pape
LM Geerdink
M Agger
M Bielaszewska
M Ferdous
Michiel F. Schreuder
N Soysal
Nicole C. A. J. van de Kar
P Mariani-Kurkdjian
RF Boer de
W Hayes
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire

Author: Bresser P
Coenen I
de Haas K
de Vries MGJ
Dijkstra NG
Dirksen CD
Geelhoed Miranda
Gelens M
Jonkers RE
Kimman ML
Koopman B
Korver Monique
Kramer H
Miedema Jelle
Moor Karen
Mostard RLM
Nossent EJ
Overbeek MJ
Peeters E
Ryan H
Storm M
Tak NC (Nelleke)
van de Kar N
van Dooren BAA
van Jaarsveld X
van Kuijk SMJ
van Manen Mirjam
van Rijswijk R
Veen A
Verhoeven L
Wegman IMH
Wetzels J
Wijnsma KL
Wijsenbeek - Lourens Marlies
Publication venue: 'Springer Science and Business Media LLC'
Publication date: 01/01/2019
Field of study

EUR Research Repository

splash!—a festival with consequences

Author: D Kavanagh
H. Friesicke
J Laurence
KL Wijnsma
M. Büttner-Herold
M. W. Baumgärtel
N Noël
T Cavero
T Goodship
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Glyco-iELISA: a highly sensitive and unambiguous serological method to diagnose STEC-HUS caused by serotype O157

Author: C Jenkins
CM Legendre
D Karpman
Diego J. Comerci
DS Castillo
E Espie
EI Schindler
Elena B. Volokhina
F Fakhouri
GJ Schwartz
H Chart
H Chart
H Chart
Juan E. Ugalde
K Ludwig
Kioa L. Wijnsma
KL Wijnsma
Lambertus P. W. J. van den Heuvel
LB Zapata-Quintanilla
LJ Melli
Nicole C. A. J. van de Kar
P Bajracharya
RF Boer de
Rik Heuver
Sheila A. M. van Bommel
Susan T. Veissi
TS Desin
X Qin
YA Soler
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire

Author: A Golay
AT Hirsh
B Ley
C Fornell
C Loirat
CA McHorney
Carmen D. Dirksen
CB Terwee
CD Dirksen
CM Utens
D Hailey
DE Hinkle
G EuroQol
H Wouters
HM Bovenkamp van de
I Hirji
J Bensing
J Jin
JC Verhave
JM Bland
JM Bland
K Facey
Kioa L. Wijnsma
KL Wijnsma
L Hu
L Richeldi
LB Mokkink
M Krahn
M Wijsenbeek
MA Ruiz
MA Trawinska
Marjolein Storm
Marlies S. Wijsenbeek
Merel L. Kimman
MJ Atkinson
ML Kimman
MR DiMatteo
N Black
N Britten
Nicole C. A. J. van de Kar
P Dolan
PP Khanna
S Strasser
Sander M. J. van Kuijk
SL Shingler
ST Mahajan
SW Al-Jabi
TE King Jr
TL Laba
W Boon
Xana van Jaarsveld
Y Rosseel
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use

Author: A Mallett
A Parikova
A Riddell
AL Sellier-Leclerc
AR Krishnan
B Michon
B Puissant-Lubrano
C Duineveld
C Levi
C Licht
C Loirat
C Loirat
C Loirat
C Wehling
Caroline Duineveld
CF Larrea
CM Legendre
CM Legendre
CM Nester
D Matar
D Ranch
D Ricklin
D Westra
DJ Legault
E Benamu
E Bresin
E Bresin
E Gavriilaki
E Volokhina
EB Volokhina
F Fakhouri
F Fakhouri
F Fakhouri
FJ Juega-Marino
G Ardissino
G Ardissino
G Ariceta
GH Struijk
H Salameh
J Caprioli
J Munch
J Nurnberger
J Zuber
J Zuber
J Zuber
JA Brand van den
Jack F. M. Wetzels
JC Verhave
JI Nishimura
JV Walle
Kioa L. Wijnsma
KL Wijnsma
KS Hodgkins
L Shochet
LA Greenbaum
LGM Andrade de
LM Geerdink
M Cugno
M Cugno
M Jamme
M Konar
M Macia
M Noris
M Noris
M Noris
M Quintrec Le
M Weitz
MA Artz
MAV Willrich
N Alachkar
N Cullinan
N Garg
N Heyne
NA Zwang
Nicole C. A. J. van de Kar
NS Sheerin
O Oyen
P Gatault
R Cofiell
RB Miller
S Chandran
S Johnson
S Krid
S Reuter
S Sinibaldi
SA Merrill
SI Al-Akash
SM Manani
T Yamamoto
TH Goodship
U Kasapoglu
V Chatelet
V Fremeaux-Bacchi
VP Scantlebury
W Hayes
Z Iqbal
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab

Author: A Dmytrijuk
A Hill
A Hill
A Mallett
A Oruc
A Roth
A Servais
AC Baines
AG Kulasekararaj
AI Davidson
AM Fitzpatrick
AS Bomback
B Puissant-Lubrano
B Yelken
C Licht
C Mele
C Wehling
C Wehling
CA De Amorim Garcia Filho
CM Legendre
CM Nester
D Coyle
D Mevorach
D Ricklin
D Sheridan
D Yuan
Dirk Jan A. R. Moes
E Volokhina
EB Volokhina
Elena. B. Volokhina
European Medicines Agency (EMA)
European Medicines Agency (EMA)
European Medicines Agency (EMA)
European Medicines Ageny (EMA)
European Medicines Ageny (EMA)
F Alashkar
F Fakhouri
F Fakhouri
F Gediz
FS De Fontbrune
G Ardissino
G Ardissino
G Ardissino
H Ninomiya
J Castaneda-Sanabria
J Schubert
J Schubert
J Zuber
JA Schatz-Jakobsen
Jack F. M. Wetzels
JF Howard Jr
JF Howard Jr
JF Howard Jr
JI Nishimura
JT Kielstein
JV Walle
JW Lee
Kioa Lente Wijnsma
KL Wijnsma
LA Greenbaum
Lambertus P. van den Heuvel
M Cugno
M Griffin
M Le Quintrec
M Sica
M Vivarelli
MAV Willrich
MC Vekemans
MD Stegall
MJ Harder
MJ Oosterveld
MK Liszewski
N Ito
Nicole C. A. J. van de Kar
P Gatault
P Hillmen
P Hillmen
P Hillmen
P Hillmen
P Hillmen
P Hillmen
R Gately
R Kelly
R Sharma
RA Brodsky
RI Jain
RJ Keizer
RJ Kelly
RJ Kelly
Rob ter Heine
Roger J. Brüggemann
RP De Latour
S Dhillon
S Jodele
S Jodele
S Jodele
S Sciascia
Saskia E. M. Schols
Saskia Langemeijer
SJ Pittock
TD Barbour
TH Goodship
UM Reiss
US Food and Drug Administration (FDA)
US Food and Drug Administration (FDA)
US Food and Drug Administration (FDA)
US Food and Drug Administration (FDA)
US Food and Drug Administration (FDA)
W Hayes
Y Delmas
Y Du
Z Yehoshua
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

core

core